Impact of Minimal Residual Disease and Chimerism Monitoring at Different Timepoints after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

被引:1
|
作者
Martin-Rojas, Reyes Maria
Oarbeascoa, Gillen
Bailen, Rebeca
Gomez-Centurion, Ignacio
Juarez, Luis Miguel
Dorado, Nieves
Martinez-Laperche, Carolina
Perez-Corral, Ana
Buno, Ismael
Anguita, Javier
Diez-Martin, Jose L.
Kwon, Mi
机构
关键词
D O I
10.1182/blood-2020-141064
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children
    Thomas Pincez
    Raoul Santiago
    Henrique Bittencourt
    Isabelle Louis
    Mélanie Bilodeau
    Alexandre Rouette
    Loubna Jouan
    Josette-Renée Landry
    Françoise Couture
    Johanne Richer
    Pierre Teira
    Michel Duval
    Sonia Cellot
    [J]. Bone Marrow Transplantation, 2021, 56 : 2981 - 2989
  • [2] Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children
    Pincez, Thomas
    Santiago, Raoul
    Bittencourt, Henrique
    Louis, Isabelle
    Bilodeau, Melanie
    Rouette, Alexandre
    Jouan, Loubna
    Landry, Josette-Renee
    Couture, Francoise
    Richer, Johanne
    Teira, Pierre
    Duval, Michel
    Cellot, Sonia
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (12) : 2981 - 2989
  • [3] Minimal residual disease monitoring is superior to chimerism assessment for relapse prediction in acute lymphoblastic leukemia after allogeneic stem cell transplantation
    Terwey, T. H.
    Hemmati, P. G.
    Nagy, M.
    Pfeifer, H.
    Goekbuget, N.
    Brueggemann, M.
    Le Duc, T. M.
    le Coutre, P.
    Doerken, B.
    Arnold, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 138 - 138
  • [4] Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction after Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia
    Terwey, Theis Helge
    Hemmati, Philipp Georg
    Nagy, Marion
    Pfeifer, Heike
    Goekbuget, Nicola
    Brueggermann, Monika
    Le Duc, Tanja Melinh
    le Coutre, Philipp
    Doerken, Bernd
    Arnold, Renate
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (10) : 1522 - 1529
  • [5] Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation
    Uzunel, M
    Mattsson, J
    Brune, M
    Johansson, JE
    Aschan, J
    Ringdén, O
    [J]. BLOOD, 2003, 101 (02) : 469 - 472
  • [6] Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
    Dominietto, Alida
    [J]. CURRENT OPINION IN HEMATOLOGY, 2011, 18 (06) : 381 - 387
  • [7] MONITORING OF CHIMERISM IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION BY QUANTITATIVE ASSESSMENT: THE BEST TOOL FOR MONITORING OF MINIMAL RESIDUAL DISEASE?
    Bouvier, A.
    Thepot, S.
    Francois, S.
    Guardiola, P.
    Tanguy-Schmidt, A.
    Beucher, A.
    Genevieve, F.
    Hunault-Berger, M.
    Zandecki, M.
    Ifrah, N.
    Blanchet, O.
    [J]. HAEMATOLOGICA, 2014, 99 : 553 - 554
  • [8] Allogeneic Hematopoietic Stem Cell Transplantation Overcomes the Adverse Prognostic Impact of Minimal Residual Disease in Acute Myeloid Leukemia
    Oran, Betul
    Singleton, Timothy
    Ramirez, Pablo A.
    Shanley, Ryan
    Brunstein, Claudio
    Ustun, Celalettin
    Warlick, Erica D.
    Weisdorf, Daniel J.
    [J]. BLOOD, 2011, 118 (21) : 887 - 887
  • [9] Impact of NCCN Risk Stratification and Minimal Residual Disease on Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
    Lu, Yue
    Wu, Tong
    Zhao, Yan-Li
    Cao, Xing-Yu
    Liu, De-Yan
    Zhang, Jian-Ping
    Xiong, Min
    Zhou, Jia-Rui
    Sun, Rui-Juan
    Wei, Zhi-Jie
    Wang, Hui
    Wang, Tong
    Liu, Hong-Xing
    Lu, Dao-Pei
    [J]. BLOOD, 2016, 128 (22)
  • [10] Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia
    Shimomura, Yoshimitsu
    Maruoka, Hayato
    Yabushita, Tomohiro
    Hashimoto, Hisako
    Ishikawa, Takayuki
    [J]. BLOOD, 2017, 130